Balance Sheet Details

3 Months Ended

Mar. 31, 2022

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Details

4. Balance Sheet Details

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):

	March 31, 2022		December 31, 2021
Prepaid contract manufacturing expenses	$	881	$	3,808
Prepaid clinical trial expenses		2,802		1,397
Prepaid research and development expenses		300		627
Other prepaid expenses		2,679		1,218
Total	$	6,662	$	7,050

Property and equipment, Net

Property and equipment, net, consist of the following (in thousands):

	March 31, 2022			December 31, 2021
Laboratory equipment	$	2,250		$	1,830
Computer equipment		223			24
Office equipment and furniture		474			—
		2,947			1,854
Less accumulated depreciation		(494	)		(407	)
Total	$	2,453		$	1,447

Depreciation expense related to property and equipment was $0.1 million and $39,000 for the three months ended March 31, 2022 and 2021, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	March 31, 2022		December 31, 2021
Accrued research and development	$	2,900	$	2,123
Accrued clinical trial expenses		2,070		1,999
Accrued contract manufacturing expenses		4,337		906
Accrued legal expenses		407		531
Unvested early exercise liability		29		35
Accrued other		746		456
Total	$	10,488	$	6,050